Bone turnover markers and prediction of fracture: A prospective follow-up study of 1040 elderly women for a mean of 9 years

Journal of Bone and Mineral Research

Volumn 25, Issue 2, 2010, Pages 393-403

  Ivaska, Kaisa K ^a,b   Gerdhem, Paul ^a,c,d   Väänänen, H Kalervo ^b   Åkesson, Kristina ^a   Obrant, Karl J ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone turnover markers; Longitudinal; Osteoporotic fracture; Prospective; TRACP5b

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; OSTEOCALCIN; BIOLOGICAL MARKER;

AGED; ARTICLE; BONE TURNOVER; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GROUPS BY AGE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLE; URINALYSIS; VERTEBRA FRACTURE; BLOOD; BONE DENSITY; COMPLICATION; FRACTURES, BONE; HIP FRACTURES; INCIDENCE; METABOLISM; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; RISK FACTOR; TIME; URINE;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HIP FRACTURES; HUMANS; INCIDENCE; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; TIME FACTORS;

EID: 77953452345     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091006     Document Type: Article

References (30)

1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-650. (Pubitemid 23166713)
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA. 2001; 285:785-795.
3. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761-1767.
4. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. WHO Tech Rep Ser 1994;843:1-129.
5. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-1259.
6. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20:1185-1194. (Pubitemid 40863806)
7. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34:195-202. (Pubitemid 38142449)
8. Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005; 90:2787-2793.
9. Sanders KM, Nicholson GC, Watts JJ, et al. Half the burden of fragility fractures in the community occur in women without osteoporosis: when is fracture prevention cost-effective? Bone. 2006;38:694-700.
10. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18:1033-1046. (Pubitemid 47020000)
11. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385-397.
12. Garnero P. Markers of bone turnover for the prediction of fracture risk. Osteoporos Int. 2000;11:S55-S65.
13. Gerdhem P, Ivaska KK, Alatalo SL, et al. Biochemical markers of bone metabolism and prediction of fracture in elderly women. J Bone Miner Res. 2004;19:386-393. (Pubitemid 38787393)
14. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996;11:1531-1538. (Pubitemid 26331009)
15. Bruyere O, Collette J, Delmas P, et al. Interest of biochemical markers of bone turnover for long-termprediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas. 2003;44:259-265. (Pubitemid 36412177)
16. Schousboe JT, Bauer DC, Nyman JA, Kane RL, Melton LJ, Ensrud KE. Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy. Osteoporos Int. 2007;18:201-210.
17. Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. 2005;20:1813-1819. (Pubitemid 41361882)
18. Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther. 2008;12:157-170. (Pubitemid 351754589)
19. Kakonen SM, Hellman J, Karp M, et al. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem. 2000;46:332-337. (Pubitemid 30152258)
20. Ivaska KK, Kakonen SM, Gerdhem P, Obrant KJ, Pettersson K, Vaananen HK. Urinary osteocalcin as a marker of bone metabolism. Clin Chem. 2005;51:618-628. (Pubitemid 40300239)
21. Gerdhem P, Akesson K. Rates of fracture in participants and non-participants in the Osteoporosis Prospective Risk Assessment study. J Bone Joint Surg Br. 2007;89:1627-1631. (Pubitemid 351183415)
22. Melton LJ III, Crowson CS, O'Fallon WM, Wahner HW, Riggs BL. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res. 2003;18:312-318.
23. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int. 2000;11:S30-S44. (Pubitemid 32039511)
24. Ivaska KK, Lenora J, Gerdhem P, Akesson K, Vaananen HK, Obrant KJ. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab. 2008;93:2622-2632. (Pubitemid 352008529)
25. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000;15:1526-1536. (Pubitemid 30484522)
26. Dobnig H, Piswanger-Solkner JC, Obermayer-Pietsch B, et al. Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements. J Clin Endocrinol Metab. 2007;92:1678-1686. (Pubitemid 46997171)
27. Iki M, Morita A, Ikeda Y, et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int. 2006;17:1086-1095. (Pubitemid 43864861)
28. Hans D, Schott AM, Duboeuf F, Durosier C, Meunier PJ. Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study. Bone. 2004;35:357-363. (Pubitemid 38953180)
29. Greenspan SL, Myers ER, Maitland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA. 1994;271:128-133. (Pubitemid 24020589)
30. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone. 2002;30:886-890. (Pubitemid 34616018)